← Back to Search

Oocytes with AI for Infertility (NiOS Trial)

N/A
Recruiting
Research Sponsored by Ovation Fertility
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 to 7 days
Awards & highlights
No Placebo-Only Group

Summary

The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.

Eligible Conditions
  • Infertility

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 to 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 to 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compare blastocyst development rate
Secondary study objectives
Euploidy Rate
Fertilization Rate
Morphological Blastocyst Quality
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Oocytes without AIExperimental Treatment0 Interventions
Oocytes randomly selected
Group II: Oocytes with AIExperimental Treatment1 Intervention
Oocytes assessed by the Magenta software

Find a Location

Who is running the clinical trial?

Ovation FertilityLead Sponsor
4 Previous Clinical Trials
762 Total Patients Enrolled
3 Trials studying Infertility
700 Patients Enrolled for Infertility
Future FertilityUNKNOWN
~244 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top